Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2

Cell Cycle

Volumn 9, Issue 7, 2010, Pages 1333-1341

  Huang, Yue ^a   Guigon, Celine J ^b   Fan, Jun ^a   Cheng, Sheue Yann ^b   Zhu, Guo Zhang ^a  

^a MARSHALL UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cyclin D2; Homeodomain transcription factor; PITX2; Thyroid cancer; catenin signaling

Indexed keywords

CYCLIN D1; CYCLIN D2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR PITX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THYROID CANCER; UPREGULATION;

MUS;

EID: 77953586705     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.7.11126     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2008. CA, A Cancer Journal for Clinicians 2008; 58:20-2.
2. Davies L, Welch HG. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002. JAMA 2006; 295:2164-7.
3. Nikiforova MN, Nikiforov YE. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 2008; 8:83-95.
4. Mesa C Jr, Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, et al. Conditional Activation of RET/PTC3 and BRAFV600E in Thyroid Cells Is Associated with Gene Expression Profiles that Predict a Preferential Role of BRAF in Extracellular Matrix Remodeling. Cancer Res 2006; 66:6521-9. (Pubitemid 44085606)
5. Schlumberger M, Carlomagno F, Baudin E, Bidart JM, Santoro M. New therapeutic approaches to treat medullary thyroid carcinoma. Nat Clin Pract End Met 2008; 4:22-32. (Pubitemid 350291115)
6. Castellone MD, De Falco V, Rao DM, Bellelli R, Muthu M, Basolo F, et al. The {beta}-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation. Cancer Res 2009; 69:1867-76.
7. Gujral TS, van Veelen W, Richardson DS, Myers SM, Meens JA, Acton DS, et al. A Novel RET Kinase-{beta}-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma. Cancer Res 2008; 68:1338-46.
8. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng S-y. Regulation of {beta}-Catenin by a Novel Nongenomic Action of Thyroid Hormone {beta} Receptor. Mol Cell Biol 2008; 28:4598-608. (Pubitemid 351977757)
9. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, et al. Identification of a Wnt/Dvl/ [beta]-Catenin→Pitx2 Pathway Mediating Cell-Type-Specific Proliferation during Development. Cell 2002; 111:673-85.
10. 1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 2003; 100:3245-50.
11. Bamforth SDBJ, Farthing CR, Schneider JE, Broadbent C, Michell AC, Clarke K, et al. Cited2 control left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet 2004; 36:1189-96.
12. Ai D, Wang J, Amen M, Lu M-F, Amendt BA, Martin JF. Nuclear Factor 1 and T-Cell Factor/LEF Recognition Elements Regulate Pitx2 Transcription in Pituitary Development. Mol Cell Biol 2007; 27:5765-75.
13. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999; 401:279-82.
14. Liu C, Liu W, Palie J, Lu MF, Brown NA, Martin JF. Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 2002; 129:5081-91.
15. Semina EV, Reiter RS, Murray JC. Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet 1997; 6:2109-16.
16. Lines MA, Kozlowski K, Walter MA. Molecular genetics of Axenfeld-Rieger malformations. Hum Mol Genet 2002; 11:1177-87.
17. Espinoza HM, Cox CJ, Semina EV, Amendt BA. A molecular basis for differential developmental anomalies in Axenfeld-Rieger syndrome. Hum Mol Genet 2002; 11:743-53.
18. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 2000; 97:13209-14.
19. Suzuki H, Willingham MC, Cheng S-y. Mice with a Mutation in the Thyroid Hormone Receptor beta Gene Spontaneously Develop Thyroid Carcinoma: A Mouse Model of Thyroid Carcinogenesis. Thyroid 2002; 12:963-9.
20. Denicourt C, Legault P, McNabb FAC, Rassart E. Human and mouse cyclin D2 splice variants: transforming activity and subcellular localization. Oncogene 2007; 27:1253-62. (Pubitemid 351294698)
21. Kida A, Kakihana K, Kotani S, Kurosu T, Miura O. Glycogen synthase kinase-3[beta] and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin// proteasome-dependent degradation in hematopoietic cells. Oncogene 2007; 26:6630-40. (Pubitemid 47573686)
22. Mullany LKWP, Hanse EA, Nelsen CJ, Goggin MM, Mullany JE, Anttila CK, et al. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 2008; 7:2215-24.
23. Kim CS, Vasko VV, Kato Y, Kruhlak M, Saji M, Cheng S-Y, Ringel MD. AKT Activation Promotes Metastasis in a Mouse Model of Follicular Thyroid Carcinoma. Endocrinology 2005; 146:4456-63. (Pubitemid 41324044)
24. Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, Engelhardt JF, Amendt BA. PITX2 and {beta}-Catenin Interactions Regulate Lef-1 Isoform Expression. Mol Cell Biol 2007; 27:7560-73. (Pubitemid 350033661)
25. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF, Amendt BA. PITX2, {beta}-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 2005; 118:1129-37. (Pubitemid 40528684)
26. Huang Y, Huang K, Boskovic G, Dementieva Y, Denvir J, Primerano DA, Zhu G-Z. Proteomic and genomic analysis of PITX2 interacting and regulating networks. FEBS Letters 2009; 583:638-42.
27. Jurchott K, Bergmann S, Stein U, Walther W, Janz M, Manni I, et al. YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression. J Biol Chem 2003; 278:27988-96. (Pubitemid 36899994)
28. Stratford A, Habibi G, Astanehe A, Jiang H, Hu K, Park E, et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res 2007; 9:61.
29. Ito Y, Yoshida H, Shibahara K, Uruno T, Nakano K, Takamura Y, et al. Y-box binding protein expression in thyroid neoplasms: Its linkage with anaplastic transformation. Pathol Int 2003; 53:429-33.
30. Huang Y, Fan J, Yang J, Zhu G-Z. Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. Mol Cell Biochem 2008; 308:133-9.
31. Furumoto H, Ying H, Chandramouli GVR, Zhao L, Walker RL, Meltzer PS, et al. An Unliganded Thyroid Hormone {beta} Receptor Activates the Cyclin D1/Cyclin-Dependent Kinase/Retinoblastoma/E2F Pathway and Induces Pituitary Tumorigenesis. Mol Cell Biol 2005; 25:124-35.
32. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature 2003; 421:290-4.